genet
clinic
epidemiolog
data
well
experiment
cell
anim
studi
support
role
reninangiotensin
system
ra
pathogenesi
alzheim
diseas
ad
mani
proinflammatori
anticholinerg
vasopressor
action
ra
associ
pathogenesi
ad
mediat
angiotensin
ii
ang
ii
signal
angiotensin
ii
type
receptor
commonli
refer
classic
axi
review
intracerebroventricular
infus
ang
ii
increas
via
increas
amyloidogen
process
amyloid
precursor
protein
app
tau
patholog
also
reduc
cognit
perform
age
normal
rat
previous
report
angiotensinconvert
ratelimit
enzym
product
angiotensin
ii
ang
ii
increas
ad
human
brain
tissu
angiotensin
ii
type
receptor
blocker
arb
angiotensinconvert
enzym
inhibitor
acei
reduc
amount
adlik
patholog
improv
cognit
perform
mous
model
ad
translat
treatment
ad
also
support
secondari
outcom
clinic
trial
variou
arb
acei
well
epidemiolog
studi
preval
ad
reduc
last
indel
polymorph
genet
risk
factor
sporad
ad
find
previous
support
sever
metaanalys
recent
genomewid
associ
studi
zinc
metallopeptidas
share
sequenc
homolog
within
catalyt
region
metalloproteas
express
mostli
transmembran
protein
also
exist
activ
solubl
truncat
form
express
predominantli
endotheli
arteri
smooth
muscl
cell
throughout
bodi
also
express
nonvascular
cell
within
brain
includ
neuron
cell
bodi
astrogli
cell
upon
discoveri
shown
gener
angiotensin
ang
ang
ii
lesser
extent
angiotensin
ang
ang
emerg
data
suggest
convers
ang
ii
ang
subsequ
activ
ma
receptor
ang
compris
ma
axi
oppos
local
action
classic
ra
pathway
peripheri
review
brain
review
experiment
anim
studi
regul
blood
pressur
counteract
effect
classic
axi
reduct
express
implic
cardiac
renal
patholog
review
associ
chronic
hypertens
activ
brain
shown
neuroprotect
anim
model
ischaem
stroke
previou
studi
suggest
link
reduc
activ
ma
axi
neurodegen
condit
includ
multipl
sclerosi
recent
studi
provid
first
clue
associ
ad
report
reduc
serum
activ
patient
ad
compar
control
subject
notabl
studi
also
identifi
convert
earli
deposit
highli
amyloidogen
form
seed
plaqu
format
turn
cleav
less
toxic
speci
ang
level
also
reduc
mous
model
sporad
ad
associ
hyperphosphoryl
tau
present
studi
investig
express
distribut
relat
ad
patholog
classic
ra
axi
human
postmortem
brain
tissu
show
first
time
knowledg
activ
reduc
human
postmortem
brain
tissu
ad
relat
tau
patholog
also
correl
invers
activ
also
show
ratio
ang
ii
ang
proxi
measur
activ
increas
ad
indic
reduc
convers
ang
ii
ang
togeth
data
indic
ma
axi
dysregul
ad
loss
function
regulatori
arm
ra
may
contribut
least
part
overactiv
classic
ra
axi
associ
ad
pathogenesi
brain
tissu
obtain
south
west
dementia
brain
bank
univers
bristol
uk
local
research
ethic
committe
approv
nation
research
ethic
servic
tissu
dissect
midfront
cortex
brodmann
area
case
ad
agematch
control
brain
subject
detail
neuropatholog
assess
accord
nation
institut
agingalzheim
associ
guidelin
ad
patholog
suffici
explan
dementia
case
control
brain
peopl
histori
dementia
extens
assess
neuropatholog
absent
neurit
plaqu
braak
tangl
stage
iii
less
neuropatholog
abnorm
demograph
data
case
present
tabl
medic
research
council
uk
brain
bank
network
mrc
ukbbn
databas
identifi
shown
addit
file
tabl
previou
measur
activ
measur
fluorogen
activ
assay
avail
case
total
solubl
nonidet
insolubl
guanidin
hydrochlorideextract
level
measur
previous
sandwich
enzymelink
immunosorb
assay
elisa
cerebr
amyloid
angiopathi
caa
sever
grade
semiquantit
scale
method
adapt
olichney
et
al
previous
report
phosphoryl
tau
ptau
load
area
fraction
cerebr
cortex
immunoposit
ptau
measur
case
previous
report
genotyp
data
alu
insert
delet
indel
polymorph
intron
gene
previous
report
last
case
previous
apolipoprotein
e
apo
genotyp
polymeras
chain
reaction
method
right
cerebr
cortex
fix
formalin
minimum
week
tissu
process
paraffin
block
taken
patholog
assess
left
cerebr
hemispher
slice
frozen
use
biochem
assess
case
mg
dissect
frozen
brain
tissu
homogenis
precelli
homogenis
stretton
scientif
stretton
uk
previous
describ
sampl
centrifug
rpm
clarifi
supernat
aliquot
store
requir
total
protein
measur
use
total
protein
kit
sigmaaldrich
pool
uk
follow
manufactur
guidelin
brain
tissu
obtain
within
h
death
activ
measur
brain
tissu
use
activ
assay
kit
catalogu
number
anaspec
fremont
ca
usa
assay
perform
black
flatbottom
nonbind
nunc
fluoronunc
plate
fisher
scientif
loughborough
uk
follow
manufactur
guidelin
minor
modif
brain
tissu
homogen
prepar
assay
buffer
provid
kit
triton
ad
sampl
centrifug
rpm
minut
supernat
remov
store
use
supernat
dilut
proprietari
assay
buffer
incub
minut
room
temperatur
prior
addit
fluoresc
reson
energi
transfer
fret
peptid
incub
minut
dark
cleavag
fret
peptid
measur
use
bmg
fluostar
optima
micropl
reader
bmg
labtech
aylesburi
uk
excitationemiss
wavelength
nm
activ
interpol
serial
dilut
mca
fluoresc
refer
standard
measur
case
repeat
duplic
confirm
specif
commerci
assay
kit
measur
activ
subset
sampl
ten
control
ten
ad
previous
measur
activ
outlin
assay
perform
black
flatbottom
nonbind
nunc
fluoronunc
plate
recombin
human
ngml
r
system
cambridg
uk
brain
tissu
supernat
dilut
dilut
assay
buffer
mm
tri
nacl
ph
preincub
specif
inhibitor
calbiochem
nottingham
uk
assay
buffer
alon
minut
fluorogen
peptid
mcaapk
dnp
enzo
life
scienc
exet
uk
ad
reaction
incub
minut
dark
fluoresc
read
excitationemiss
wavelength
nm
use
bmg
fluostar
optima
micropl
reader
activ
calcul
subtract
fluoresc
presenc
uninhibit
sampl
observ
strong
correl
independ
measur
presenc
kit
indic
specif
assay
kit
addit
file
figur
ang
ii
level
measur
brain
tissu
homogen
extract
sd
lysi
buffer
nacl
mm
tri
ph
phenylmethylsulphonylfluorid
aprotinin
sigmaaldrich
sd
distil
water
use
commerci
avail
sandwich
elisa
kit
abcam
cambridg
uk
follow
manufactur
guidelin
brief
recombin
human
ang
ii
brain
tissu
supernat
dilut
pb
ad
duplic
well
precoat
ang
iispecif
captur
antibodi
incub
h
room
temperatur
wash
step
well
incub
h
biotinyl
antiang
ii
antibodi
room
temperatur
plate
wash
follow
incub
streptavidinhrp
final
wash
tmb
substrat
ad
minut
absorb
nm
read
use
fluostar
optima
plate
reader
concentr
ang
ii
interpol
serial
dilut
recombin
ang
ii
pgml
measur
duplic
case
ang
level
measur
human
brain
tissu
homogen
sd
lysi
buffer
see
use
inhous
direct
elisa
kit
recombin
human
ang
enzo
life
scienc
human
brain
tissu
homogen
dilut
pb
incub
h
clear
high
bind
capac
nunc
maxisorp
plate
thermo
fisher
scientif
waltham
usa
shake
well
wash
five
time
pb
block
h
bovin
serum
albumin
sigmaaldrich
anoth
five
wash
well
incub
biotinyl
antihuman
ang
pb
cloudclon
wuhan
china
h
shake
follow
wash
step
streptavidinhrp
ad
well
incub
room
temperatur
minut
dark
tmb
substrat
r
system
ad
wash
left
develop
dark
minut
absorb
nm
read
follow
addit
n
sulphur
acid
stop
solut
use
fluostar
optima
plate
reader
ang
concentr
interpol
standard
curv
gener
serial
dilut
recombin
human
ang
pgml
assay
show
minim
crossreact
number
close
relat
peptid
includ
ang
ang
ii
ang
iii
formalinfix
paraffinembed
tissu
section
cut
dewax
prior
immunohistochemistri
section
pretreat
trisodium
citrat
buffer
mm
ph
microwav
minut
left
stand
minut
boil
minut
left
stand
minut
room
temperatur
section
rins
thoroughli
cover
hors
serum
block
solut
rins
incub
overnight
room
temperatur
antibodi
abcam
bound
antibodi
visualis
use
biotinyl
univers
antibodi
follow
vectastain
elit
abc
avidinbiotin
complex
kit
vector
laboratori
peterborough
uk
reaction
specif
antibodi
assess
preadsorpt
antibodi
molar
excess
recombin
human
protein
r
system
unpair
twotail
test
analysi
varianc
anova
bonferroni
post
hoc
analysi
use
comparison
group
pearson
test
use
assess
linear
correl
spss
version
spss
chicago
il
usa
graphpad
prism
version
graphpad
softwar
la
jolla
ca
usa
softwar
p
valu
consid
statist
signific
activ
significantli
reduc
approxim
midfront
cortex
ad
compar
agematch
control
p
fig
vari
accord
diseas
sever
control
ad
case
group
stratifi
follow
braak
tangl
stage
group
vvi
p
anova
post
hoc
analysi
use
bonferroni
correct
multipl
comparison
reveal
activ
significantli
reduc
braak
tangl
stage
compar
stage
p
stage
p
fig
differ
observ
braak
stage
stage
combin
ad
control
cohort
activ
correl
invers
total
insolubl
level
r
p
fig
solubl
data
shown
correl
invers
activ
r
p
addit
file
figur
correl
invers
ptau
load
r
p
fig
activ
significantli
lower
individu
possess
apo
allel
establish
genet
risk
factor
sporad
ad
without
p
fig
activ
also
differ
significantli
indel
genotyp
p
individu
homozyg
ii
previous
associ
increas
risk
ad
lowest
activ
although
post
hoc
analysi
reveal
reach
statist
signific
fig
assess
activ
relat
caa
sever
found
activ
tendenc
although
signific
toward
increas
activ
case
moder
sever
caa
compar
absent
mild
caa
p
fig
activ
correl
invers
activ
combin
ad
control
cohort
r
p
fig
pattern
observ
remain
statist
signific
control
r
p
ad
r
p
group
analys
separ
previou
report
suggest
ratio
good
proxi
measur
activ
statu
classic
regulatori
ra
pathway
mind
calcul
ratio
case
found
significantli
increas
ad
compar
control
p
fig
ratio
also
correl
posit
insolubl
level
approach
signific
r
p
fig
significantli
ptau
r
p
fig
ratio
increas
individu
possess
apo
allel
approach
signific
p
fig
differ
significantli
accord
indel
polymorph
p
post
hoc
analysi
reveal
ratio
significantli
higher
individu
ii
ad
risk
factor
dd
p
id
dd
p
fig
ang
ii
level
significantli
increas
midfront
cortex
ad
compar
agematch
control
p
fig
wherea
ang
level
unchang
fig
calcul
ang
iiang
ratio
proxi
indic
activ
found
ang
iiang
ratio
significantli
increas
ad
p
fig
data
indic
convers
ang
ii
ang
like
reduc
ad
lower
activ
localis
primarili
capillari
also
perivascular
distribut
around
larger
arteriol
fig
label
nonvascular
cell
strongli
resembl
astrocyt
fig
c
label
observ
preadsorpt
antibodi
recombin
human
demonstr
specif
antibodi
fig
present
studi
show
activ
reduc
postmortem
brain
tissu
ad
associ
increas
tau
patholog
reduct
pronounc
individu
carri
apo
allel
homozyg
ii
indel
polymorph
suggest
genet
risk
factor
ad
activ
correl
invers
activ
previous
shown
increas
ad
ratio
higher
ad
togeth
data
strongli
suggest
reduc
activ
within
brain
contribut
ad
pathogenesi
associ
increas
activ
central
classic
ra
axi
brain
intrins
ra
shown
previou
studi
ratelimit
enzym
product
ang
ii
overact
ad
wide
accept
ang
iimedi
signal
via
commonli
term
classic
axi
overact
ad
associ
ad
pathogenesi
review
view
support
variou
anim
studi
infus
ang
ii
result
elev
plaqu
tau
patholog
signific
cognit
impair
secondari
observ
clinic
trial
epidemiolog
studi
provid
evid
rastarget
drug
either
block
product
ang
ii
prevent
signal
reduc
preval
ad
cognit
perform
improv
patholog
reduc
anim
model
ad
recent
prevail
view
ra
ad
oversimplifi
fail
consid
contribut
downstream
ra
regulatori
pathway
within
brain
studi
found
reduc
brain
activ
ad
support
recent
studi
show
lower
peripher
serum
level
ad
activ
correl
invers
parenchym
load
increas
ptau
level
also
observ
strong
invers
relationship
activ
suggest
may
contribut
way
regul
amyloidogen
process
app
sever
possibl
mechan
link
reduc
activ
pathogenesi
ad
firstli
lower
activ
via
lower
convers
ang
ii
ang
result
elev
ang
ii
level
shown
studi
increas
ang
iiang
ratio
commonli
report
chronic
condit
associ
overactiv
central
axi
secondli
primarili
respons
gener
ang
ang
ii
subsequ
ang
activ
ma
receptor
counterregul
detriment
effect
classic
axi
link
enhanc
learn
memori
process
lastli
recent
shown
convert
highli
amyloidogen
form
seed
plaqu
format
turn
cleav
lesser
extent
reduc
toxic
lower
activ
ad
may
therefor
promot
earli
deposit
prevent
downstream
cleavag
data
suggest
put
protect
role
ma
pathway
develop
patholog
also
declin
cognit
function
lost
ad
find
indic
balanc
classic
axi
regulatori
ma
axi
ra
disturb
ad
previous
shown
variou
mous
model
cardiovascular
diseas
diabet
nephropathi
activ
reduc
ad
invers
correl
increas
activ
ratio
increas
ad
associ
diseas
patholog
find
support
commonli
observ
trait
cardiac
renal
patholog
show
dysregul
ma
pathway
includ
reduc
activ
associ
sustain
hypertens
mediat
overactiv
classic
axi
review
despit
ratio
ang
ii
ang
proxi
measur
activ
increas
ad
ie
reduc
convers
ang
ii
ang
observ
overal
reduct
total
ang
ad
inconsist
recent
report
show
reduc
serum
ang
level
rather
reduc
activ
senescenceacceler
mous
prone
mous
model
sporad
ad
involv
overexpress
app
author
observ
ang
level
correl
invers
ang
ii
ptau
level
reason
discrep
find
human
mous
brain
tissu
unclear
howev
studi
indic
ma
pathway
dysregul
ad
work
requir
determin
exact
contribut
compon
pathway
ad
activ
ma
pathway
induc
activ
infus
ang
ma
receptor
agonist
protect
variou
experiment
anim
model
cardiovascular
diseas
associ
reduct
classic
ra
pathway
review
neuron
overexpress
brain
also
neuroprotect
chronic
hypertens
mous
model
transgen
renin
angiotensinogen
overproduc
ang
ii
follow
experiment
induct
ischaem
stroke
protect
effect
partial
revers
presenc
ma
receptor
antagonist
demonstr
specif
ma
pathway
shown
mediat
counterregul
effect
ang
iimedi
reactiv
oxygen
speci
product
ad
grow
recognit
reposit
brainpenetr
arb
acei
may
clinic
benefit
ad
addit
reduc
central
pool
ang
ii
arb
acei
might
also
exert
protect
effect
prevent
reduct
activ
revers
arb
activ
also
associ
reduc
activ
downregul
ang
ii
level
express
studi
suggest
activ
may
exert
protect
effect
ad
beyond
dampen
ra
activ
use
acei
arb
current
allow
lastli
explor
distribut
within
midfront
tempor
cortic
found
localis
predominantli
within
endotheli
cell
smooth
muscl
cell
cerebr
arteri
previous
report
interestingli
also
observ
extens
perivascular
express
found
activ
increas
individu
moder
sever
caa
previous
shown
specul
sequenti
cleavag
first
subsequ
cleavag
predomin
speci
caa
provid
potenti
mechanist
link
caa
studi
requir
determin
relationship
caa
sever
data
indic
reduc
activ
ma
axi
strongli
link
overact
classic
ra
pathway
adrel
patholog
